Related Experiment Video
Updated: Sep 29, 2025

10:28
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
9.9K
Step-up approach in emphysematous hepatitis: A case report.
Silke Francois1, Maridi Aerts2, Hendrik Reynaert2
1Department of Gastroenterology, Universitair Ziekenhuis Brussel, Brussels 1090, Belgium. silkefrancois@gmail.com.
World Journal of Hepatology
|March 23, 2022
Summary
Emphysematous hepatitis (EH) is a rare, fatal liver infection. A successful step-up treatment approach involving antibiotics, drainage, and surgery offers hope for managing this critical condition.
Area of Science:
- Hepatology
- Infectious Diseases
- Surgical Gastroenterology
Background:
- Emphysematous hepatitis (EH) is a rare, rapidly progressive, gas-forming infection of the liver.
- This fulminant condition predominantly affects patients with diabetes mellitus.
- EH carries a high mortality rate, necessitating prompt recognition and intervention.
Observation:
- A case of EH was successfully managed using a comprehensive step-up treatment strategy.
- The treatment included aggressive hemodynamic support, intravenous antibiotics, and percutaneous drainage.
- Laparoscopic deroofing was performed as a subsequent step in the management.
Findings:
- The reported case demonstrates a successful outcome with the step-up approach.
- Compared to previous literature, where only 1 of 11 documented EH cases survived (via urgent laparotomy and debridement), this case highlights an alternative successful management pathway.
- This suggests that a tailored, multi-modal approach may improve survival rates in EH.
Implications:
- Timely diagnosis of emphysematous hepatitis is crucial for effective management.
- The described step-up treatment strategy offers a potentially life-saving alternative to aggressive surgical debridement.
- Further research into optimal management protocols for EH is warranted to improve patient outcomes.
Keywords:
Case reportEmphysematous hepatitisLaparoscopic deroofingPercutaneous drainageSeptic shockStep-up approachMore Related Videos
Related Concept Videos
Pneumonia II: Pathophysiology
830
The pathophysiology of pneumonia involves the following steps:
830
Pneumonia I: Introduction
368
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
368
Acute Respiratory Failure-II
410
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
410
Acute Respiratory Failure-III
370
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
370
Pneumonia IV: Management
476
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
476
Pneumonia III: Complications and Assessment
495
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
495

